Loading...

TSBX TURNSTONE BIOLOGICS CORP Business Restructuring 8-K Filing

TRNS

TSBX

TURNSTONE BIOLOGICS CORP

(TSBX)

2024 8-K

Show Summary

Show Summary

Financial Statements

Stock Delisting

Financial Results

Strategic Alternatives

Workforce Reduction

Nasdaq Compliance Notice

Financial Results

Annual Meeting Results

Financial Results Announcement

Departure of Directors

Earnings Reports

Regulation FD Disclosure

Initial Public Offerings

External Links:

Turnstone Biologics Corp. announced a strategic workforce reduction of about 60%, incurring an estimated $2.3 million in severance costs, to focus on its Phase 1 program, TIDAL-01, and also made several leadership changes including the appointment of

AI Assistant

TURNSTONE BIOLOGICS CORP

2024

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.